Related Articles
MED23 in endocrinotherapy for breast cancer
[Corrigendum] Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway
Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice
EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)